Brief: Diaxonhit H1 net loss widens to 3.9 million euros

Eurobio Scientific SA

21/09/2016 06:30

Sept 21 (Reuters) - Diaxonhit SA  ALEHT.PA : 
    * H1 revenue 15.3 million euros ($17.0 million) versus 16.0 million euros year ago 
    * H1 net loss of 3.9 million euros versus loss of 2.3 million euros year ago 
    * H1 operating loss of 4.1 million euros versus loss of 3.4 million euros year ago 
    * Cash position on June 30 was 7.3 million euros 
    * Consolidated definitive results of final validation study of Dx15 should be released in H1 
2017 
    * Dx15 could be launched from 2018 
 
Source text for Eikon:  ID:nGNE7TXJ52  
Further company coverage:  ALEHT.PA  
 
($1 = 0.8985 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))